Aeglea BioTherapeutics Inc. (AGLE) climbed 5.89% or 0.63 to $11.31. It is near 535605 shares traded, which is 173.16% compare to the average total volume 309314. The market cap of AGLE is $247.20 million. The year to date change is 98.51%. The 52 week price range is from $2.81 to $11.35. Price of AGLE have changed 9.88% during last week. It have changed 14.35% over last month, 47.31% over last 3 months, 167.00% over last 6 months and 153.08% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AGLE is 9.62. It is -14.94% below current price. The 200-day Moving Averages for AGLE is 6.46. It is -42.88% below current price. The 52-week High is 11.35. It is 0.35% from the current price. The 52-week Low is 2.81. It is -75.15% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AGLE is 0.07 on 2018-05-15. Short % to float is 0.11%. There are some statistics of AGLE. It is has market cap $247.20 million. The share outstanding is 21.86 million. The average volume is 309314. The revenue is 2.74M. The percent of top 15 Institution holding is 57.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AGLE is -57.58%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AGLE is -52.42%.